Pathophysiology and Pharmacology of COPD Flashcards
What is COPD ?
progressive development of airflow obstruction that is irreversible
COPD destroys the alveoli
Symptoms of COPD
- wheezing
- breathlessness
- cough
- sputum production
- infective exacerbations
Common causes of COPD
- smoking
- air pollution
- exposure to fumes and dust
- chest infection during the first year of life
- early nutrition
- genetic factors
Chronic bronchitis ( a mucus problem )
hypertrophy and hyperplasia of submucosal glands - increased mucus production - increase in goblet cell - increased mucus production - mucociliary dysfunction - builds up mucus in the airways
Reduces amount of CO2 excretion and 02 inhalation
Natural narrowing of airways that occurs during exhalation plus presence of mucus plugs leads to air trapping in alveoli . This leads to decrease in partial pressure of O2 and increase partial pressure of CO2.
Accumulation of mucus also makes an ideal environment for bacteria to grow and cause infections which poses an increased risk of pneumonia
Emphysema ( an inflammatory and structural problem )
- destruction of elastic leads to narrowing and collapse of airways and alveoli.
- this air trapping inside the alveoli
- this is turn leads to decrease partial pressure of O2 and an increase in partial pressure of CO2
LOW VENTILATION CAN LEAD TO HYPOXEMIC VASOCONSTRICTION - PULMONARY HYPERTENSION - RIGHT VENTRICULAR FAILURE
Natural course of COPD
- breathlessness initially on exercise and also on rest.
- cough and scutum production initially in morning but later all day.
- acute respiratory infections with increasing frequency especially in winter.
- hypoxia initially on exercise but later during sleep and even at rest by day leading to pulmonary hypertension
- chronic respiratory failure
- terminal acute respiratory failure
STOP SMOKING
- nicotine replacement therapy
- psychological counselling, group therapy
COPD THERAPY
- Bronchodilators
- short acting bronchodilators initially such as salbutamol or terbutaline.
- then long acting B2 agonists such as salmeterol
- M3 muscarinic antagonists more effective EG. long active tiotropium - Anti-inflammatory therapy
- modest effect of corticosteroids such as inhaled beclomethasone
- PDE4 inhibitors - Oxygen therapy
Bronchodilator therapy
- B2 AGONISTS = acts on B2 receptors on bronchial smooth muscle to produce relaxation and dilation of airways. Also, improve mucociliary clearance and inhibit neutrophil recruitment and activation
- Anticholinergics = musacrinic receptor antagonists ; ie they block M3 receptor mediated smooth muscle contraction and secretion of mucus. More effective than B2 agonists
Vaccination to avoid acute infective exacerbation of COPD
- symptoms are often associated with viral influenza A and B or bacterial ( streptococcus ) infection of the airways
- acute exacerbations are associated with increased morbidity and mortality in COPD
TREATMENT OPTIONS
- vaccination for influenza A and B, injection with inactivated virus or live attenuated virus as nasal drops
- vaccination for streptococcus pneumonia